Evaluation of Efficacy and Safety of Iloperidone in the Treatment of Bipolar I Disorder
Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate the efficacy, safety, and tolerability of iloperidone
compared with placebo in treating acute manic or mixed episodes associated with Bipolar I
Disorder.